An Individual Patient Supply Program for Ruxolitinib for the Treatment of Patients with Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF).

Barosi, G., Agarwal, M., Zweegman, S., Willenbacher, W., Pakstyte, S., Raymakers, R., … Harrison, C. N. (2012). An Individual Patient Supply Program for Ruxolitinib for the Treatment of Patients with Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF). Blood, 120(21), 2844–2844. https://doi.org/10.1182/blood.v120.21.2844.2844